“Health-Related Quality of Life (HRQL) in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated with Cemiplimab: Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s122. doi:10.25251/skin.4.supp.122.